Sands Capital Alternatives as of Sept. 30, 2025
Portfolio Holdings for Sands Capital Alternatives
Sands Capital Alternatives holds 20 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nu Hldgs Ord Shs Cl A (NU) | 25.2 | $115M | 7.2M | 16.01 | |
| Klaviyo Com Ser A (KVYO) | 21.3 | $97M | 3.5M | 27.69 | |
| Beta Bionics (BBNX) | 15.5 | $71M | 3.6M | 19.87 | |
| Coupang Cl A (CPNG) | 5.6 | $26M | 795k | 32.20 | |
| Doordash Cl A (DASH) | 5.4 | $25M | 90k | 271.99 | |
| Samsara Com Cl A (IOT) | 4.9 | $22M | 599k | 37.25 | |
| Inhibikase Therapeutics Com New (IKT) | 3.9 | $18M | 11M | 1.62 | |
| Datadog Cl A Com (DDOG) | 3.7 | $17M | 119k | 142.40 | |
| Monday SHS (MNDY) | 2.5 | $11M | 58k | 193.69 | |
| Tarsus Pharmaceuticals (TARS) | 2.2 | $10M | 170k | 59.43 | |
| Crowdstrike Hldgs Cl A (CRWD) | 1.7 | $7.7M | 16k | 490.38 | |
| Snowflake Com Shs (SNOW) | 1.3 | $6.1M | 27k | 225.55 | |
| Acumen Pharmaceuticals (ABOS) | 1.3 | $5.8M | 3.4M | 1.71 | |
| Toast Cl A (TOST) | 1.3 | $5.7M | 157k | 36.51 | |
| 10x Genomics Cl A Com (TXG) | 1.2 | $5.6M | 482k | 11.69 | |
| Bioage Labs (BIOA) | 1.0 | $4.6M | 786k | 5.88 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.8 | $3.8M | 2.1M | 1.81 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $2.4M | 725k | 3.27 | |
| Candel Therapeutics (CADL) | 0.5 | $2.1M | 406k | 5.10 | |
| Figma Class A Com Stk (FIG) | 0.2 | $949k | 18k | 51.87 |
